HCPCS J7214

Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.

HCPCS Information

HCPCS Code: J7214
The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J7214 identifies the type of service or supply used while any of the 6 NDC codes below could be used to specify the exact drug used.
Short Description
Altuviiio per factor viii iu
Long Description
Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.
Pricing Indicator
Drugs
Multiple Pricing Indicator
Not applicable as HCPCS priced under one methodology
Coverage Description
Carrier judgment
BETOS Type of Service
Other drugs
Medicare Payment Limit
$4.67
Medicare Co-Insurance Percentage
20.000%
HCPCS Classification
List of HCPCS codes for: Drugs Administered Other Than Oral Method, Chemotherapy Drugs (J-codes)

HCPCS Crossover to NDC Codes

The NDC codes below allow precise billing based on the specific manufacturer and medication used:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
71104-978Altuviiio Antihemophilic Factor (recombinant), Fc-vwf-xten Fusion Protein-ehtlKitBioverativ Therapeutics Inc.ACTIVE
71104-979Altuviiio Antihemophilic Factor (recombinant), Fc-vwf-xten Fusion Protein-ehtlKitBioverativ Therapeutics Inc.ACTIVE
71104-981Altuviiio Antihemophilic Factor (recombinant), Fc-vwf-xten Fusion Protein-ehtlKitBioverativ Therapeutics Inc.ACTIVE
71104-982Altuviiio Antihemophilic Factor (recombinant), Fc-vwf-xten Fusion Protein-ehtlKitBioverativ Therapeutics Inc.ACTIVE
71104-983Altuviiio Antihemophilic Factor (recombinant), Fc-vwf-xten Fusion Protein-ehtlKitBioverativ Therapeutics Inc.ACTIVE
71104-984Altuviiio Antihemophilic Factor (recombinant), Fc-vwf-xten Fusion Protein-ehtlKitBioverativ Therapeutics Inc.ACTIVE